-
EP3106148
European procedure
Extract from the Register of European Patents
EP About this file: EP3106148
| EP3106148 - ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.01.2019 Database last updated on 28.05.2024 | |
| Former | The patent has been granted Status updated on 09.02.2018 | ||
| Former | Grant of patent is intended Status updated on 03.10.2017 | ||
| Former | Examination is in progress Status updated on 07.07.2017 | ||
| Former | Request for examination was made Status updated on 20.01.2017 | ||
| Former | The application has been published Status updated on 18.11.2016 | Most recent event Tooltip | 18.01.2019 | No opposition filed within time limit | published on 20.02.2019 [2019/08] | Applicant(s) | For all designated states Mithra Pharmaceuticals S.A. Rue Saint-Georges 5-7 4000 Liège / BE | [2016/51] | Inventor(s) | 01 /
Jaspart, Séverine Francine Isabelle Rue des condruzes, 19 BE-4560 Bois-et-Borsu / BE | 02 /
Platteeuw, Johannes Jan Newtonplein 41 5283 JH Boxtel / NL | 03 /
van den Heuvel, Denny Johan Marijn Ganzeneiland 11 6642 DJ Beuningen / NL | [2016/51] | Representative(s) | Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL | [2016/51] | Application number, filing date | 16175091.4 | 17.06.2016 | [2016/51] | Priority number, date | EP20150172747 | 18.06.2015 Original published format: EP 15172747 | [2016/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3106148 | Date: | 21.12.2016 | Language: | EN | [2016/51] | Type: | B1 Patent specification | No.: | EP3106148 | Date: | 14.03.2018 | Language: | EN | [2018/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.08.2016 | Classification | IPC: | A61K9/20, A61K31/565 | [2017/40] | CPC: |
A61K31/565 (EP,CN,EA,IL,KR,US);
A61K9/0056 (EP,CN,EA,IL,KR,US);
A61K9/006 (CN,EA,IL,KR,US);
A61K9/2009 (EA,IL);
A61K9/2013 (EA,IL,US);
A61K9/2018 (EP,CN,EA,IL,KR,US);
A61K9/2027 (CN,EA,IL,KR,US);
A61K9/2054 (CN,EA,IL,KR,US);
A61K9/2059 (CN,EA,IL,KR,US);
A61K9/2072 (EA,IL,US);
A61K9/2077 (EP,EA,IL,KR,US);
A61K9/2095 (EP,CN,EA,IL,KR,US);
A61P15/18 (EP,CN,EA,IL,KR);
A61P43/00 (EP,CN,EA,IL);
A61P5/00 (CN);
A61P5/30 (EP,CN,EA,IL)
(-)
|
| Former IPC [2016/51] | A61K9/00, A61K9/20, A61K31/565 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/08] |
| Former [2016/51] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | SCHMELZENDE DARREICHUNGSEINHEIT MIT EINER ESTETROLKOMPONENTE | [2016/51] | English: | ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT | [2016/51] | French: | UNITÉ POSOLOGIQUE ORODISPERSIBLE CONTENANT UN COMPOSANT D'ESTÉTROL | [2016/51] | Examination procedure | 17.06.2016 | Date on which the examining division has become responsible | 10.01.2017 | Amendment by applicant (claims and/or description) | 10.01.2017 | Examination requested [2017/08] | 10.07.2017 | Despatch of a communication from the examining division (Time limit: M04) | 11.08.2017 | Reply to a communication from the examining division | 04.10.2017 | Communication of intention to grant the patent | 31.01.2018 | Fee for grant paid | 31.01.2018 | Fee for publishing/printing paid | 31.01.2018 | Receipt of the translation of the claim(s) | Opposition(s) | 17.12.2018 | No opposition filed within time limit [2019/08] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 14.03.2018 | [2018/46] | Documents cited: | Search | [Y]WO0042955 (PLACE VIRGIL A [US]) [Y] 1-19 * page 2, line 6 - page 3, line 14 * * page 4, lines 19-25 ** example - *; | [YD]WO02094276 (PANTARHEI BIOSCIENCE BV [NL], et al) [YD] 1-19 * the whole document *; | [Y]US2005070488 (COELINGH BENNIK HERMAN JAN TIJ [NL], et al) [Y] 1-19 * paragraph [0035] - paragraph [0037] * * paragraph [0048] - paragraph [0050] * * paragraph [0060] * * paragraph [0098] * * example 6 *; | [Y]US2007286819 (DEVRIES TINA [US], et al) [Y] 1-19 * paragraph [0003] * * paragraph [0018] * * paragraph [0021] * * examples 1,2 *; | [XP]WO2015086643 (DONESTA BIOSCIENCE B V [NL]) [XP] 1-19 * page 4, line 24 - page 6, line 27 * * page 11, line 17 - line 25 * * page 12, line 17 - line 25 * * claim - * | by applicant | US6117446 | WO02094275 | WO02094276 | WO02094278 | WO02094279 | WO03018026 | WO03041718 | WO2007081206 | US2007286829 | WO2008156365 | WO2010033832 |